Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Gain insights into the cash back credit card payout process to understand how and when you’ll receive your rewards.
12,844 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A harsh winter trimmed fishing days and boosted costs for Maine’s lobster sector, even as 2025 revenue stayed above $...
ServiceNow's stock is down this year, but CEO Bill McDermott argues AI will accelerate growth, not derail it, outlini...
Mind Robotics has rapidly transformed Rivian's focus, reaching a multi-billion dollar valuation. Learn the two key wa...
Micron stock just popped again as banks boosted targets and demand signals showed improvement. This guide breaks down...
Nvidia trades around $199 per share as investors weigh whether the AI winner can also be a true value stock. The deba...
FuelCell Energy slumped 22% on Monday as investors rebalanced the AI-powered hydrogen rally, with Plug Power down 12%...
QUBT surged alongside quantum peers on policy chatter, but the rally raises questions about fundamentals and governme...
As AI rivals surge and cloud demand shifts, investors question Microsoft’s staying power in the Magnificent 7. The de...
A prominent hedge fund just sold its entire XPeng stake, triggering questions for everyday investors. Learn how to ev...
A clear look at a Vanguard mega-cap ETF with a heavy tilt toward four tech giants, what that means for risk and retur...
Anthropic stunned markets with a Series H that values the private AI firm near $1 trillion, signaling a new era for p...